Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Transdermal System
.
Show all posts
Showing posts with label
Transdermal System
.
Show all posts
Thursday, May 5, 2022
FDA Approves Xelstrym (dextroamphetamine) Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
›
Noven Pharmaceuticals, Inc., awholly-ownedsubsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that the U.S. Food and Drug Admi...
Thursday, March 12, 2020
FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia
›
In continuation of my update on Asenapine Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutica...
Thursday, November 28, 2019
FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia
›
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Admin...
›
Home
View web version
